Skip to main content

Table 1 Clinical characteristics of 170 HCC patients and correlation with MAGL staining

From: Monoacylglycerol lipase promotes progression of hepatocellular carcinoma via NF-κB-mediated epithelial-mesenchymal transition

 

MAGL staining

Variables

Low (n = 77) n(%)

High (n = 93) n(%)

P

Gender

 Male

67 (87.0)

78 (83.9)

0.565

 Female

10 (13.0)

15 (16.1)

 

Age(years)

 ≤50

28 (36.4)

37 (39.8)

0.648

 >50

49 (63.6)

56 (60.2)

 

HBsAg

 Negative

14 (18.2)

11 (11.8)

0.244

 Positive

63 (81.8)

82 (88.2)

 

HCV

 Negative

74 (96.1)

91 (97.8)

0.659

 Positive

3 (3.9)

2 (2.2)

 

Liver cirrhosis

 No

30 (39.0)

29 (31.2)

0.289

 Yes

47 (61.0)

64 (68.8)

 

AFP(ng/ml)

 ≤20

28 (36.4)

23 (24.7)

0.099

 >20

49 (63.6)

70 (75.3)

 

Tumor number

 Single

56 (72.7)

55 (59.1)

0.064

 Multiple

21 (27.3)

38 (40.9)

 

Tumor size(cm)

 ≤5

44 (57.1)

39 (41.9)

0.048

 >5

33 (42.9)

54 (58.1)

 

Tumor encapsulation

 Complete

37 (48.1)

49 (52.7)

0.547

 Incomplete

40 (51.9)

44 (47.3)

 

Microvascular invasion

 Absent

48 (62.3)

42 (45.2)

0.026

 Present

29 (37.7)

51 (54.8)

 

Edmondson grade

 I–II

16 (20.8)

36 (38.7)

0.012

 III–IV

61 (79.2)

57 (61.3)

 

TNM stage

 I

18 (23.4)

5 (5.4)

0.001

 II–III

59 (76.6)

88 (94.6)

 
  1. HBsAg hepatitis B surface antigen, HCV hepatitis C virus, AFP alpha fetoprotein, TNM tumor node metastasis, MAGL monoacylglycerol lipase
  2. Italic numbers means P < 0.05